Human Immunodeficiency Virus (HIV)-Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral Therapy.

MLA

Anderson, Jenny L., et al. “Human Immunodeficiency Virus (HIV)-Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral Therapy.” The Journal of Infectious Diseases, vol. 221, no. 5, Feb. 2020, pp. 744–55. EBSCOhost, https://doi.org/10.1093/infdis/jiz509.

APA

Anderson, J. L., Khoury, G., Fromentin, R., Solomon, A., Chomont, N., Sinclair, E., Milush, J. M., Hartogensis, W., Bacchetti, P., Roche, M., Tumpach, C., Gartner, M., Pitman, M. C., Epling, C. L., Hoh, R., Hecht, F. M., Somsouk, M., Cameron, P. U., Deeks, S. G., & Lewin, S. R. (2020). Human Immunodeficiency Virus (HIV)-Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral Therapy. The Journal of Infectious Diseases, 221(5), 744–755. https://doi.org/10.1093/infdis/jiz509

Chicago

Anderson, Jenny L, Gabriela Khoury, Rémi Fromentin, Ajantha Solomon, Nicolas Chomont, Elizabeth Sinclair, Jeffrey M Milush, et al. 2020. “Human Immunodeficiency Virus (HIV)-Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral Therapy.” The Journal of Infectious Diseases 221 (5): 744–55. doi:10.1093/infdis/jiz509.